Found 8 matching trials
CART-meso in Mesothelin Expressing Cancers
PHASE1Phase I study to establish safety and feasibility of intravenously administ...
Location
Abramson Cancer Center of the University of Pennsylvania
Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART-meso
PHASE1RATIONALE: Placing a tumor antigen chimeric receptor that has been created ...
Location
Biotherapeutic Department and Pediatrics Department of Chinese PLA General Hospital
The Fourth Generation CART-cell Therapy for Refractory-Relapsed Ovarian Cancer
EARLY_PHASE1The goal of this clinical trial is to study the safety and feasibility of a...
Location
Shanghai 6th People's Hospital
CART-meso Long-term Follow-up
N/AThis is a non-therapeutic, long-term follow-up (LTFU) study of subjects who...
Location
University of Pennsylvania
A Study of Mesothelin Redirected Autologous T Cells for Advanced Pancreatic Carcinoma
PHASE1Pancreatic carcinoma typically has a high recurrence rate and very poor pro...
Location
Renji Hospital, Shanghai Jiao Tong University School of Medicine
Autologous Redirected RNA Meso-CIR T Cells
PHASE1To determine the safety and manufacturing feasibility of IV autologous chim...
Location
Abramson Cancer Center of the University of Pennsylvania
Pilot Study of Autologous T-cells in Patients With Metastatic Pancreatic Cancer
PHASE1This is a study in which pancreatic cancer patients receive a combination t...
Location
University of California, San Francisco
Study of Autologous T-cells in Patients With Metastatic Pancreatic Cancer
NAThis is a study in which pancreatic cancer patients receive a immunotherapy...
Location
Nanjing First Hospital